Bruno Lucidi

CIK: 0001829622

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVIR

Atea Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AVIR
Atea Pharmaceuticals, Inc.
Jun 18, 2026
Exercise(M)
Direct
29.6K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jun 18, 2026
Award(A)
Restricted Stock Units
Direct
26.7K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jun 18, 2026
Award(A)
Stock Option (Right to Buy)
Direct
37.7K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jun 20, 2025
Exercise(M)
Direct
29.6K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jun 20, 2025
Award(A)
Restricted Stock Units
Direct
29.6K shares-
AVIR
Atea Pharmaceuticals, Inc.
Jun 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
41.2K shares-

		Type	Shares	Price		Ownership
Jun 18, 2026	AVIR Atea Pharmaceuticals, Inc.	Exercise(M)	29,600	-	$0	Direct
Jun 18, 2026	AVIR Atea Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	26,700	-	-	Direct
Jun 18, 2026	AVIR Atea Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	37,700	-	-	Direct
Jun 20, 2025	AVIR Atea Pharmaceuticals, Inc.	Exercise(M)	29,600	-	-	Direct
Jun 20, 2025	AVIR Atea Pharmaceuticals, Inc.	Award(A) Restricted Stock Units	29,600	-	-	Direct
Jun 20, 2025	AVIR Atea Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	41,200	-	-	Direct

1-6 of 6 transactions

About Lucidi Bruno

Lucidi Bruno (SEC CIK 0001829622) files insider reports with the SEC as Director of Atea Pharmaceuticals, Inc. (AVIR).

Signal8 holds 2 ownership filings by Lucidi Bruno, all Form 4s, filed between Jun 24, 2025 and Jun 23, 2026. Those filings report 6 transactions, from Jun 20, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lucidi Bruno's filings is in BOSTON, MA.

Recent filings by Lucidi Bruno

Jun 18, 2026: Option exercise of AVIR shares (Form 4, code M).
Jun 18, 2026: Grants or awards of AVIR derivative securities (2 lines, Form 4, code A).
Jun 20, 2025: Option exercise of AVIR shares (Form 4, code M).
Jun 20, 2025: Grants or awards of AVIR derivative securities (2 lines, Form 4, code A).

Other insiders filing for Atea Pharmaceuticals, Inc. (AVIR)

BERGER FRANKLIN M, Director
Berman Howard, Director
DUNCAN BARBARA GAYLE, Director
Polsky Bruce, Director
Murphy Polly A., Director
Adams Jerome M., Director

How to read Form 4 transaction codes